This issue contains 7 items, and the estimated reading time is 3 minutes.

Orthopedic Giant Completes Three Acquisitions in Six Months

StrykerAnnounced the completion ofArtelonThe acquisition of the latter, a privately held company focused onInnovative Foot and Ankle Soft Tissue Fixation Products and the Field of Sports Medicine。

According to Stryker's previous disclosure, this acquisition willStrengthen Stryker's products in the soft tissue fixation field, and emphasized that Stryker is committed to providing differentiated solutions for ligament and tendon reconstruction.

This is alreadyStryker's Third Acquisition Completed Within the Last Six Months。

In March, it completed the acquisition ofFrench Joint Replacement Company SERF SASThe acquisition. SERF SAS's innovations in the field of hip implants have drawn attention, including the development of dual-mobility total hip replacements. In April, it completed the acquisition ofmfPHDThe acquisition. mfPHD is a leader in modular stainless steel wall systems for hospitals and outpatient surgery centers.

Abbott Reports Second Quarter 2024 Earnings and Raises Full-Year Profit ForecastAbbott's Total Sales in Q2 2024: $10.377 Billion, an increase of 4% year-on-year. Sales grew organically by 7.4%, and excluding COVID testing sales, the growth was 9.3%.

2024Q2 Abbott MedicalGrowth Achieved Across Four Sectors: Equipment, Diagnostics, Pharmaceuticals, and NutraceuticalsAmong them, the medical device sector performed the most outstandingly, achieving double-digit growth.

Specifically, Abbott in 2024Q2Medical device business sales reached $4.734 billion, with a reported growth of 10.2% and organic growth of 12.1%, significantly outpacing other sectors.。

Johnson & Johnson Q2 Earnings: Electrophysiology Grows by 13.4%

Johnson & Johnson Releases Q2 2024 Earnings Report. The report shows,Johnson & Johnson's Q2 2024 revenue was $22.45 billion, a year-on-year increase of 4.3%.The total revenue for the first half of the year was 43.83 billion US dollars, a year-on-year increase of 3.3%. Among them,Medical Technology Business Q2 Revenue of $7.957 Billion, Up 2.2% Year-over-Year. Its four business lines are relatively balanced, among whichCardiovascular Business Line Grew by 15.6% Year-on-Year。Electrophysiology Achieved Double-Digit Growth of 13.4%, with Strong Growth Across All Regions。

Considering the costs associated with a recent series of acquisitions, Johnson & JohnsonDowngraded the full-year profit forecast。

Da Vinci Q2 Performance Shines

Intuitive Surgical Releases Q2 Financial Report, Exceeding Wall Street's Consensus Estimates

2024H1 Medical Device Companies' IPO: 1 Success, 13 Failures

Source: MedTrend

AI Medical Imaging Market: Annual Compound Growth Rate of 34.7%

Source: Market.us Media

• From the perspective of imaging methods,CT scans account for the largest market share, at 37.4%.; X-ray shows rapid growth, with a compound annual growth rate of 37.1%.

• From the analysis of the application field,Neurology dominates in use, accounting for 39.8% of the share.; Breast cancer screening is the fastest-growing application, with a compound annual growth rate of 36.4%.

• From a technical perspective,Deep learning technology accounts for 58.8% of the market share., Natural Language Processing (NLP) is the fastest-growing technology, with an annual compound growth rate of 37.6%.

• In terms of the terminal market,Hospitals are the primary users of AI imaging technology, accounting for 53.7% of the market share., while diagnostic imaging centers are rapidly expanding at an annual compound growth rate of 35.6%.

According to incomplete statistics, last week (7.15-7.21) there were a total of5 financing events, among which2Early-stage Project Financing(Pre-A round and previous rounds),No billion-dollar large-scale financing。